Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01517763 · ClinicalTrials.gov registry record · NA

Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients

A NA study, sponsored by Fisher and Paykel Healthcare.

Terminated
Registry status
NA
Development phase
32
Enrollment target

NCT01517763: Clinical Trial NA study, sponsored by Fisher and Paykel Healthcare.

NCT01517763 is a NA study that was terminated before completion, run by Fisher and Paykel Healthcare. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01517763, a NA study, was terminated before completion, sponsored by Fisher and Paykel Healthcare.

TERMINATED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

A total of 216 patients will be randomized into a partially single blind, randomized, parallel-arm trial to determine whether the ICON™ AT with SensAwake™ and ThermoSmart™ can improve therapy adherence when compared to standard care with a fixed pressure Continuous Positive Airway Pressure (CPAP) device and compared to a less aesthetically pleasing CPAP device without technologies (AutoCPAP, SensAwake™, ThermoSmart™) in patients previously diagnosed with moderate-severe obstructive sleep apnea (OSA).

Interventions

  • DEVICE Conventional CPAP Therapy
  • DEVICE Fixed pressure ICON™ without ThermoSmart™
  • DEVICE Auto ICON™ with SensAwake™ and ThermoSmart™

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2012-01
Est. Completion 2014-09
Phase NA
Fisher and Paykel Healthcare

25 total trials

Why NCT01517763 stopped before completion

NCT01517763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 3 interventions - of which Conventional CPAP Therapy is the first listed.

NCT01517763 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01517763 about?

NCT01517763 is a clinical study titled "Comparison Study of the ICON™ Auto Series With and Without SensAwake™ and ThermoSmart™ and Conventional Continuous Positive Airway Pressure in Obstructive Sleep Apnea Patients". A total of 216 patients will be randomized into a partially single blind, randomized, parallel-arm trial to determine whether the ICON™ AT with SensAwake™ and ThermoSmart™ can improve therapy adherence when compared to standard care with a fixed pressure Continuous Positive Airway Pressure (CPAP) de...

What is the current status of trial NCT01517763?

This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2012-01. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01517763?

The interventions under investigation include: Conventional CPAP Therapy (DEVICE), Fixed pressure ICON™ without ThermoSmart™ (DEVICE), Auto ICON™ with SensAwake™ and ThermoSmart™ (DEVICE).

Who is sponsoring clinical trial NCT01517763?

This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01517763's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01517763, the US trial registry maintained by the National Library of Medicine. NCT01517763 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.